Posts  / #POST-255531
BLOG

Problems at Twist Bioscience (TWST)

S
Nov 5, 2026 · 15:40

<div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" href="https://substackcdn.com/image/fetch/$s_!YCSR!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F565ff8ad-4342-4051-8512-009387f60a94_800x532.gif" target="_blank"><div class="image2-inset"><source type="image/webp" /><img alt="" class="sizing-normal" height="532" src="https://substackcdn.com/image/fetch/$s_!YCSR!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F565ff8ad-4342-4051-8512-009387f60a94_800x532.gif" width="800" /><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button class="pencraft pc-reset pencraft icon-container restack-image buttonBase-GK1x3M" tabindex="0" type="button"><svg class="icon-noB79L" fill="none" height="20" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" stroke-width="1.5" viewBox="0 0 20 20" width="20" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button class="pencraft pc-reset pencraft icon-container view-image buttonBase-GK1x3M" tabindex="0" type="button"><svg class="lucide lucide-maximize2 lucide-maximize-2 icon-noB79L" fill="none" height="20" stroke="currentColor" stroke-linecap="round" stroke-linejoin="round" stroke-width="2" viewBox="0 0 24 24" width="20" xmlns="http://www.w3.org/2000/svg"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a><figcaption class="image-caption">Graphic by Daniel DeLorenzo</figcaption></figure></div><p><strong>BY: <a href="https://hntrbrk.com/team/nathaniel-horwitz">Nathaniel Horwitz</a></strong></p><p><strong>EDITOR: <a href="https://hntrbrk.com/team/vikas-kumar-jd">Vikas Kumar</a></strong></p><p>This is a rare article for The Bear Cave by Hunterbrook&#8217;s CEO, who was previously a biomedical entrepreneur and investor. There is no investment position based on this article. Full bio and disclosures below.</p><div><hr /></div><p><em>I used Twist in work with Anthropic, interviewed its CEO, and once lost over $30 million investing in an alarmingly similar story. Amid a hype cycle and a short squeeze, TWST reclaimed its highs from the last techbio bubble. But despite a compelling CEO and rapid growth, Twist is mostly another lab vendor, trading at a rich valuation versus peers.</em></p><p><em>Last time, TWST fell 95%. Could it happen again?</em></p><div><hr /></div><p>In October, I co-authored a <a href="https://www-cdn.anthropic.com/31ac578806cffd8b3d92d8affe6edc4c04d502e1.pdf">technical report</a> with Anthropic. We used an <a href="https://hntrbrk.com/investigations/antivenom">unreleased AI model</a> to design an experimental antivenom. Twist and Adaptyv, two lab vendors, helped us test our designs.</p><div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" href="https://substackcdn.com/image/fetch/$s_!O8KN!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fec7a4e14-e11a-44d1-b21b-17b2a8d5d2df_1949x901.png" target="_blank"><div class="image2-inset"><source type="image/webp" /><img alt="" class="sizing-normal" height="673" src="https://substackcdn.com/image/fetch/$s_!O8KN!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fec7a4e14-e11a-44d1-b21b-17b2a8d5d2df_1949x901.png" width="1456" /><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button class="pencraft pc-reset pencraft icon-container restack-image buttonBase-GK1x3M" tabindex="0" type="button"><svg class="icon-noB79L" fill="none" height="20" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" stroke-width="1.5" viewBox="0 0 20 20" width="20" xmlns="http://www.w3.org/2000/svg"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button class="pencraft pc-reset pencraft icon-container view-image buttonBase-GK1x3M" tabindex="0" type="button"><svg class="lucide lucide-maximize2 lucide-maximize-2 icon-noB79L" fill="none" height="20" stroke="currentColor" stroke-linecap="round" stroke-linejoin="round" stroke-width="2" viewBox="0 0 24 24" width="20" xmlns="http://www.w3.org/2000/svg"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p>A similar <a href="https://www.anthropic.com/research/Claude-accelerates-protein-design">technical report</a> in August had catalyzed a short squeeze in TWST, with many investors claiming the report meant that Twist was partnered with Anthropic. That squeeze helped <a href="https://www.macrotrends.net/stocks/charts/TWST/twist-bioscience/stock-price-history">return</a> Twist to around $200 a share, its <a href="https://www.macrotrends.net/stocks/charts/TWST/twist-bioscience/stock-price-history#google_vignette">previous high</a> in 2021.</p><p>After that earlier peak, TWST fell 95%.</p><p>My experience using Twist with Anthropic, interviews with Twist executives and biotech experts, and a detailed review of its financials suggest that the valuation may have overshot again.</p><p>Twist sells life science tools and services to biomedical clients. If you need DNA for a gene, or protein for a drug candidate, Twist is one of your options. Twist assesses proteins, such as the ability of a drug candidate to bind its target. It also sells reagents for sequencing.</p><p>CEO Emily Leproust co-founded Twist in 2013, then <a href="https://investors.twistbioscience.com/news-releases/news-release-details/twist-bioscience-announces-settlement-agreement-agilent/">settled litigation</a> with her prior employer &#8212; giant lab vendor Agilent &#8212; over her alleged theft of the foundational tech, paying $22.5 million without admission of wrongdoing. Twist went public as TWST in 2018.</p><p>The bull case today is that increasing demand, Twist&#8217;s scale and operating leverage, and the expansion of its platform to additional markets have vaulted the company into a higher echelon than other lab vendors. It&#8217;s a strong pitch.</p><p>But customers have alternatives. Several other vendors provide similar services at similar prices. Twist faces competition across essentially everything it offers. And TWST already trades at the highest multiple among peers.</p><p>Behind the paywall, The Bear Cave takes premium readers through the business, my recent interview with the CEO, the competitive landscape, and different valuation scenarios. While Twist may post good earnings next week &#8212; the CEO struck a bullish tone in our conversation &#8212; our reporting explains why that may not be enough to justify the current TWST stock price.</p><p><em><strong>Disclosure: </strong>The Bear Cave is now owned by Hunterbrook Media. Hunterbrook Media&#8217;s investment affiliate, Hunterbrook Capital, does not have any positions related to this article at the time of publication. Positions may change at any time. See full disclosures <a href="https://thebearcave.substack.com/p/disclaimer">here</a>.</em></p>
<p>
<a href="https://thebearcave.substack.com/p/problems-at-twist-bioscience-twst">
Read more
</a>
</p>